Trevi Therapeutics
TRVI
#6339
Rank
A$0.97 B
Marketcap
$10.11
Share price
1.89%
Change (1 day)
159.71%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$72.72 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$44.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -A$74.93 Million67%
2023 -A$44.87 Million2.43%
2022 -A$43.81 Million-14.45%
2021 -A$51.21 Million1.36%
2020 -A$50.52 Million23.64%
2019 -A$40.86 Million27.54%
2018 -A$32.04 Million